1
/
of
1
Elabscience
SKU:E-EL-H2370
Human proPSA(precursor of Prostate Specific Antigen) ELISA Kit
Human proPSA(precursor of Prostate Specific Antigen) ELISA Kit
Regular price
$609.00 USD
Regular price
Sale price
$609.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Human proPSA (precursor of Prostate Specific Antigen) ELISA Kit, a cutting-edge solution designed to accurately measure the levels of proPSA in human samples. This advanced kit is meticulously crafted to provide researchers, clinicians, and laboratory professionals with a reliable and efficient tool for prostate cancer diagnosis and monitoring.
The Human proPSA ELISA Kit utilizes the enzyme-linked immunosorbent assay (ELISA) technique, a widely recognized and validated method in the field of medical diagnostics. With its high sensitivity and specificity, this kit enables precise quantification of proPSA, a crucial biomarker associated with prostate cancer progression and recurrence.
Crafted with utmost precision, this kit ensures optimal performance and reproducibility. Each component is meticulously selected and rigorously tested to guarantee accuracy and reliability. The kit includes all necessary reagents, standards, and controls, simplifying the experimental process and minimizing potential errors.
The Human proPSA ELISA Kit boasts a wide dynamic range, allowing for the detection of proPSA levels across a broad spectrum. This versatility enables the measurement of both low and high concentrations, facilitating comprehensive analysis and enhancing diagnostic capabilities.
Furthermore, this kit offers exceptional convenience and efficiency. With a streamlined protocol and user-friendly instructions, it enables seamless integration into laboratory workflows, saving valuable time and resources. The kit's compatibility with standard laboratory equipment ensures effortless implementation, making it an ideal choice for laboratories of varying scales.
In summary, the Human proPSA ELISA Kit is a state-of-the-art solution that empowers researchers, clinicians, and laboratory professionals in their pursuit of accurate prostate cancer diagnosis and monitoring. With its unparalleled sensitivity, specificity, and convenience, this kit is poised to revolutionize the field of prostate cancer diagnostics, ultimately contributing to improved patient outcomes and enhanced healthcare practices.
The Human proPSA ELISA Kit utilizes the enzyme-linked immunosorbent assay (ELISA) technique, a widely recognized and validated method in the field of medical diagnostics. With its high sensitivity and specificity, this kit enables precise quantification of proPSA, a crucial biomarker associated with prostate cancer progression and recurrence.
Crafted with utmost precision, this kit ensures optimal performance and reproducibility. Each component is meticulously selected and rigorously tested to guarantee accuracy and reliability. The kit includes all necessary reagents, standards, and controls, simplifying the experimental process and minimizing potential errors.
The Human proPSA ELISA Kit boasts a wide dynamic range, allowing for the detection of proPSA levels across a broad spectrum. This versatility enables the measurement of both low and high concentrations, facilitating comprehensive analysis and enhancing diagnostic capabilities.
Furthermore, this kit offers exceptional convenience and efficiency. With a streamlined protocol and user-friendly instructions, it enables seamless integration into laboratory workflows, saving valuable time and resources. The kit's compatibility with standard laboratory equipment ensures effortless implementation, making it an ideal choice for laboratories of varying scales.
In summary, the Human proPSA ELISA Kit is a state-of-the-art solution that empowers researchers, clinicians, and laboratory professionals in their pursuit of accurate prostate cancer diagnosis and monitoring. With its unparalleled sensitivity, specificity, and convenience, this kit is poised to revolutionize the field of prostate cancer diagnostics, ultimately contributing to improved patient outcomes and enhanced healthcare practices.
Share
